Expert Insights
Expert Insights
Podcast Description
Expert Insights offers an inside look at the diagnostics industry, with practical advice and real-world examples from experienced professionals. Hosted by Mitzi Rettinger, Chief Revenue Officer at DCN Dx, this podcast focuses on the key decisions and challenges involved in developing and commercializing diagnostic technologies.
Each episode features conversations with industry experts who share their experiences in assay development, clinical research, manufacturing, and regulatory processes. From overcoming technical hurdles to ensuring a smooth path to market, Expert Insights provides clear, actionable guidance for diagnostics developers, R&D managers, and innovators.
Subscribe to Expert Insights on Spotify, Apple Podcasts, or your preferred platform, and visit dcndx.com for additional tools and resources.
Podcast Insights
Content Themes
The podcast centers on key themes related to diagnostics technology, including assay development, clinical research, manufacturing processes, and regulatory challenges. Specific episode examples include discussions like 'Developing Your Lateral Flow Development Skills' where practical training in assay development is emphasized, reflecting a focus on actionable guidance for listeners needing real-world insights.

DCN Dx Expert Insights is a podcast for teams developing and commercializing in vitro diagnostics. Each episode brings together scientists, clinical researchers, regulatory specialists, manufacturing experts, and industry leaders to examine the decisions that determine whether an IVD program reaches the market.
Topics include assay development, clinical evidence, regulatory strategy, biospecimens, manufacturing, scale-up, product development, and commercialization.
Subscribe to Expert Insights on Spotify, Apple Podcasts, or your preferred platform, and visit dcndx.com for additional tools and resources.
LISTEN AND FOLLOW
Spotify: https://open.spotify.com/show/16GcmTI4U7dhzKSQe0mUhO
Apple Podcasts: https://podcasts.apple.com/us/podcast/dcn-dx-expert-insights/id1793226272
Subscribe on YouTube: https://www.youtube.com/channel/UCgMr7XR64b1Q1_0nG-X8b1Q?sub_confirmation=1
MORE FROM DCN DX
Explore IVD articles, podcast transcripts, and technical resources: https://dcndx.com/insights/
Learn more about DCN Dx: https://dcndx.com/
Discuss your IVD program with our team: https://dcndx.com/contact/
Why do IVD clinical studies lose enrollment opportunities? Learn how testing and treatment timing, home testing, and clinic workflows affect patient recruitment in respiratory and sexually transmitted infection (STI) studies.
In Season 3, Episode 15 of Expert Insights, “Where IVD Studies Lose Enrollment: Respiratory and STI Lessons from the Sites,” Emily Friedland, Vice President of Clinical Research at DCN Dx, discusses the practical challenges of enrolling patients in in vitro diagnostic (IVD) clinical trials. She is joined by Missy Farrell, RN, BSN, CCRC, Founder and CEO of ClinicaGen Bio, and Lara Poznak, CCRA, Clinical Trial Manager at DCN Dx.
They cover:
-Why a site’s positive-test rate doesn’t establish how many patients it can enroll.
-How STI results arriving after treatment can close enrollment windows in studies that exclude treated patients.
-How home testing and telehealth affect respiratory study recruitment.
-What clinic workflows, staffing, and waiting-room capacity mean for enrollment.
-Why slowing enrollment can work better than repeatedly stopping and restarting it.
-How mock study visits can reveal workflow problems before enrollment begins.
The conversation examines how understanding daily clinic operations can help sponsors set realistic enrollment expectations and plan around the respiratory season’s short enrollment window.
To discuss enrollment planning or recruitment challenges in your diagnostic clinical study, contact DCN Dx at https://dcndx.com/contact/
Subscribe to Expert Insights for conversations about diagnostic development, clinical research, and regulatory strategy.
#IVD #ClinicalTrials #PatientRecruitment

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.